• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines

Bioengineer by Bioengineer
December 14, 2022
in Health
Reading Time: 2 mins read
0
The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277668

The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines

Credit: Allyson MacLean, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277668

Article Title: Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines

Author Countries: Canada

Funding: This study was funded in part by a COVID-19 Rapid Response grant by the Canadian Institute of Health Research (CIHR, #VR2 – 172722) and by a grant supplement by the Canadian Immunity Task Force (CITF) to MAL. MM holds a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST) and YG holds a Canadian Institute of Health Research (CIHR) Frederick Banting and Charles Best graduate scholarship (CGS-M). Production of RBD was supported financially by the National Research Council Canada Pandemic Response Challenge program. Greenhouse management was supported by funding from the University of Ottawa Faculty of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS ONE

DOI

10.1371/journal.pone.0277668

Article Title

Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines

Article Publication Date

14-Dec-2022

COI Statement

The authors have declared that no competing interests exist.

Share12Tweet8Share2ShareShareShare2

Related Posts

Monoclonal Antibodies Shield Against Drug-Resistant Klebsiella

October 1, 2025
blank

Oncotarget Editor-in-Chief Wafik S. El-Deiry to Chair 2025 WIN Symposium in Partnership with APM in Philadelphia

October 1, 2025

Linking Nurses’ Emotional Skills to Care Competence

October 1, 2025

Tracking Ovarian Cancer Evolution via Cell-Free DNA

October 1, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    90 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    65 shares
    Share 26 Tweet 16
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Early-Onset Gastric Cancer Trends in BRICS

Monoclonal Antibodies Shield Against Drug-Resistant Klebsiella

High-Frame Ultrasound Reveals Liver Cancer Insights

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.